MedPath

Alveolar Ridge Preservation Using Different Bone Substitutes

Phase 3
Completed
Conditions
Alveolar Ridge Enlargement
Interventions
Drug: Toothgraft
Drug: Allograft
Drug: Alloplast
Registration Number
NCT05812872
Lead Sponsor
Ain Shams University
Brief Summary

The primary objective of this study was to compare the efficacy of using allograft, autogenous tooth graft, and beta-tricalcium phosphate for alveolar ridge preservation (ARP) by examining the alveolar ridge height and width at baseline and 3 months after the ARP both clinically and radiographically. The secondary objective was to evaluate the quality of the newly formed bone using histomorphometric analysis.

Detailed Description

This randomized controlled clinical trial included thirty patients. ARP was performed using either Allograft (Allograft group n=10), Tooth graft (Toothgraft group n=10), and beta tri-calcium- phosphate (beta tri-calcium group n=10). Changes in alveolar ridge dimensions were evaluated clinically and radiographically using cone beam computed tomography at baseline and 3 months. Core bone biopsy samples were obtained 3 months post-extraction during implant placement for histomorphometric analysis.

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
30
Inclusion Criteria
  1. seeking implant-based restorations after tooth extraction.
  2. exhibited no evidence of any significant medical history, measured using Burket's Oral medicine health history questionnaire.
  3. exhibited Type I and II sockets
Exclusion Criteria
  1. nonsmokers.
  2. Pregnant and breast-feeding females
  3. patients with known contraindications to dental implant surgery (e.g., increased bleeding tendency, history of treatments such as radiotherapy,

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
Alveolar ridge preservationwith tooth graftToothgrafttooth graft
Alveolar ridge preservation with allograftAllograftAllograft
Alveolar ridge preservation with alloplastAlloplastBeta Tri-Calcium phosphate
Primary Outcome Measures
NameTimeMethod
Clinical assessment3 months

Bone width loss was calculated by measuring alveolar ridge width buccopalatally in millimeter using a caliper clamp. The measurement was done perpendicular to the tangent of the dental arch at the mid-point of the extraction site approximately 4mm apical to the level of the marginal gingiva of the adjacent teeth.

Secondary Outcome Measures
NameTimeMethod
Radiographic assessment3 months

Loss in bone width was calculated by measuring distance from buccal alveolar crest to palatal alveolar crest in millimeter.

Trial Locations

Locations (1)

Ain Shams University

🇪🇬

Cairo, Egypt

© Copyright 2025. All Rights Reserved by MedPath